Therefore, elucidation of how YTHDF2 is regulated and its proteolysis pathway would potentially benefit the development of new therapeutic strategies to manipulate YTHDF2 levels in cancers—such as AML [23]—or for ex vivo amplification of hematopoietic stem cells [21,22]. The gene discussed is YTHDF2; the disease is acute myeloid leukemia.